Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis.

por Ho, S., Johnson, P. J.
Publicado 1998

Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.

por Lei, K. I., Leung, W. T., Johnson, P. J.
Publicado 1994

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.

por White, Y. S., Johnson, P. J., Davison, F., Williams, R.
Publicado 1990

Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.

por Melia, W. M., Nunnerley, H. B., Johnson, P. J., Williams, R.
Publicado 1982

Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.

por Iqbal, M. J., Wilkinson, M. L., Johnson, P. J., Williams, R.
Publicado 1983

Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma.

por Johnson, P. J., Melia, W. M., Palmer, M. K., Portmann, B., Williams, R.
Publicado 1981

Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.

por Wong, I. H., Leung, T., Ho, S., Lau, W. Y., Chan, M., Johnson, P. J.
Publicado 1997

Hyperthyroxinaemia in hepatocellular carcinoma: relation to thyroid binding globulin in the clinical and preclinical stages of the disease.

por Alexopoulos, A., Hutchinson, W., Bari, A., Keating, J. J., Johnson, P. J., Williams, R.
Publicado 1988

'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.

por Johnson, P. J., Leung, N., Cheng, P., Welby, C., Leung, W. T., Lau, W. Y., Yu, S., Ho, S.
Publicado 1997

Structures of disease-specific serum alpha-fetoprotein isoforms

por Johnson, P J, Poon, T C W, Hjelm, N M, Ho, C S, Blake, C, Ho, S K W
Publicado 2000

Expression and Activity of Collagenases in the Digital Laminae of Horses with Carbohydrate Overload‐Induced Acute Laminitis

por Wang, L., Pawlak, E.A., Johnson, P.J., Belknap, J.K., Alfandari, D., Black, S.J.
Publicado 2013

Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model

por Fox, R, Berhane, S, Teng, M, Cox, T, Tada, T, Toyoda, H, Kumada, T, Kagebayashi, C, Satomura, S, Johnson, P J
Publicado 2014

Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters.

por Johnson, P. J., Dobbs, N., Kalayci, C., Aldous, M. C., Harper, P., Metivier, E. M., Williams, R.
Publicado 1992

Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma

por Teng, M, Pirrie, S, Ward, D G, Assi, L K, Hughes, R G, Stocken, D, Johnson, P J
Publicado 2014

Rensching cats and dogs: feeding ecology and fecundity trends explain variation in the allometry of sexual size dimorphism

por Johnson, P. J., Noonan, M. J., Kitchener, A. C., Harrington, L. A., Newman, C., Macdonald, D. W.
Publicado 2017

Modelling prognostic factors in advanced pancreatic cancer

por Stocken, D D, Hassan, A B, Altman, D G, Billingham, L J, Bramhall, S R, Johnson, P J, Freemantle, N
Publicado 2008

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom

por Palmer, D H, Hussain, S A, Smith, A J, Hargreaves, S, Ma, Y T, Hull, D, Johnson, P J, Ross, P J
Publicado 2013

Preclinical and post-treatment changes in the HCC-associated serum proteome

por Ward, D G, Cheng, Y, N'Kontchou, G, Thar, T T, Barget, N, Wei, W, Martin, A, Beaugrand, M, Johnson, P J
Publicado 2006

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

por Yeo, W, Zee, B, Zhong, S, Chan, P K S, Wong, W-L, Ho, W M, Lam, K C, Johnson, P J
Publicado 2004

Identification of macrophage migration inhibitory factor and human neutrophil peptides 1–3 as potential biomarkers for gastric cancer

por Mohri, Y, Mohri, T, Wei, W, Qi, Y-J, Martin, A, Miki, C, Kusunoki, M, Ward, D G, Johnson, P J
Publicado 2009